ASS1 and myxofibrosarcoma: Association of low ASS1 expression with poor overall survival has been reported in multiple cancers, including bladder [50], myxofibrosarcoma [51], and breast cancer [52], although the number of breast cancer patients included was limited (n = 149) and all subtypes were analyzed.